Innovate UK

StimOxyGen is a biotechnology company focused on developing innovative, pH-responsive nanoparticles. These nanoparticles are designed to generate oxygen in hypoxic (low oxygen) tumors, enhancing the effectiveness of cancer treatments like radiotherapy and chemotherapy. The company's core technology involves a nanoparticle formulation that dissolves in the low pH environment of tumors, transiently producing oxygen and thereby maximizing the therapeutic effects of radiotherapy.

AllFocal Optics revolutionizes display technology through groundbreaking nanophotonic solutions.

Ultima Forma, based in the UK, is a pioneering manufacturer focused on developing advanced metallic engineering components. The company specializes in creating intricate, lightweight, high-strength parts featuring tailored nanoengineered characteristics across multiple materials. Their innovative process enables them to produce complex 3D structures with locally optimized properties, offering versatile solutions for various industries.

Beta Bugs is an insect genetics company specializing in the development and distribution of high-performance Black Soldier Fly breeds aimed at enhancing productivity in the insect protein sector. The company operates a breeding program called HiPer-Fly® and maintains a dedicated egg production site known as The Multiplier®, supplying its breeds to both UK and international markets. By focusing on biotechnology and breeding techniques, Beta Bugs aims to create a sustainable protein source that can effectively replace traditional feed ingredients such as fishmeal and soymeal in livestock, aquaculture, and pet feed. Headquartered at the Easter Bush Campus, a recognized center for animal genetics, Beta Bugs collaborates closely with the Roslin Institute, noted for its pioneering work in animal genetics.

Quinas is a leading-edge developer of revolutionary next-generation dual-use semiconductor memory technology designed to drive the proliferation of intelligent devices for Future Compute, Novel AI and Military/Aerospace. ULTRARAM is a revolutionary new type of computer memory that was invented and is under development in the Physics Department at Lancaster University. It combines speed, endurance, retention, and energy efficiency into a single memory concept. These astonishing properties are achieved by harnessing a quantum mechanical effect called resonant tunnelling. Benefits to end user: Ultra-efficient - extending battery life and/or reducing battery weight in the field Non-volatile - data retained in the absence of power, instant reboot for fast response when power is restored. High endurance - high reliability with long lifetime High performance - no compromise in speed despite non-volatility Low carbon – reduces large system power consumption. Sectors: -Future Compute -Novel AI -Data Centres -Automotive -Military/Aerospace

Metalchemy is a pioneering technology company focused on developing and commercializing green nanotechnology solutions. It operates by transforming organic waste into valuable nanomaterials through its proprietary bio-nanotechnology processes. This innovative approach enables Metalchemy to produce eco-friendly bioplastics, contributing to reduced food waste and mitigating climate change impacts. The company's mission is to make green nanotechnology widely accessible, fostering a healthier and more sustainable future for all.

Nanovery Limited, based in London, United Kingdom, specializes in the development of nanorobots aimed at detecting cancer mutations. Incorporated in 2018, the company leverages advances in nanotechnology, medicinal chemistry, and artificial intelligence to create a platform that enables rapid and sensitive identification of challenging disease biomarkers. These nanorobots are designed to be introduced into blood samples, where they capture circulating tumor DNA and emit a fluorescent signal, facilitating point-of-care detection. This innovative approach not only aids in the early detection of cancer but also enhances the ability to predict the evolution of cancer cells, significantly improving the chances of patient survival. Supported by academic experts, clinicians, and industry leaders, Nanovery is committed to making cancer detection more efficient and accessible.

Intrinsic Semiconductor Technologies specializes in the development of silicon-oxide based resistive random-access memory (RRAM) technologies. The company focuses on creating non-volatile memory solutions that are fully air stable and compatible with complementary metal-oxide-semiconductor (CMOS) processes. Intrinsic's innovative technology can be adapted for various applications, including multilevel memory, hardware acceleration for machine learning, and neuromorphic devices. By utilizing low-power, cost-effective semiconductors and gallium nitride materials, the company enables the integration of its devices into standard CMOS architectures, even at advanced process nodes. This capability allows clients to achieve higher performance under demanding conditions, such as elevated temperatures and frequencies.

NIQS Technology is a spin-out from the University of Leeds specializing in innovative quantum glucose management solutions aimed at transforming diabetes care. The company has developed a patented, non-invasive glucose monitoring technology that employs a contact-based wearable device made of nano-engineered glass. This device mimics the optical properties of glucose, allowing for continuous, accurate glucose level monitoring without the need for needles or blood sampling. By providing accessible and user-friendly monitoring solutions, NIQS Technology seeks to empower individuals living with diabetes to manage their condition more effectively and improve their overall quality of life, while minimizing the risk of complications associated with traditional glucose management methods.

Silveray is a company focused on developing affordable large-area direct conversion detectors specifically for the X-ray imaging market. It leverages advanced core technology that delivers high-performance X-ray imaging through the use of nanoparticle-based X-ray conversion materials. These materials are produced as a semiconductor ink, which is then deposited onto a pixel backplane. This innovative approach enables healthcare providers and various industries to generate an electrical current response to detected X-ray photons, all while maintaining a sustainable cost point. Silveray aims to enhance the efficiency and accessibility of X-ray imaging solutions.

Dyman Advanced Materials specializes in the development of a patented technology aimed at enhancing the manufacturing process of synthetic diamonds. This innovative approach seeks to improve the efficiency of the traditional high-pressure and high-temperature method used in diamond synthesis, resulting in reduced production costs. By providing a more economical production method, Dyman's technology serves both the industrial and gemstone market sectors, facilitating the broader availability of high-quality synthetic diamonds.

Ionoptika is the provider of high-performance ion beam technologies for surface analysis and nanofabrication applications, and are the experts in cluster ion beams for secondary ion mass spectrometry (SIMS).

Anaphite Limited is a startup based in Bristol, United Kingdom, that specializes in the development of graphene-based nanomaterials. Founded in 2016, the company focuses on creating graphene-enhanced cathode materials designed for high-performance, cost-effective lithium-ion batteries. Anaphite's innovative approach incorporates graphene into composite materials through a scalable and economical process, resulting in advanced properties suitable for various applications, including energy storage, air purification, and thermal management. By making these nanomaterials readily accessible at a low cost, Anaphite aims to enable businesses to leverage their potential across multiple sectors.

Camallergy Limited is a biopharmaceutical company based in Cambridge, United Kingdom, founded in 2015. The company specializes in developing and manufacturing oral immunotherapy drugs, particularly targeting food allergies, with a focus on peanut allergies. Camallergy's lead product offers a novel treatment designed to provide "bite-proof" protection to patients within 14 weeks of therapy. This innovative approach is grounded in unique intellectual property and clinical research initiated at Cambridge University Hospitals NHS Foundation Trust. By aiming to deliver patient-centric solutions, Camallergy seeks to improve the quality of life for individuals suffering from food allergies, allowing them to live without the constant fear of allergic reactions.

Iceni Labs is an innovation commercialisation enterprise, with integrated research, development, test and manufacturing capability. Inter-disciplinary by nature, we combine commercial expertise with academic excellence, across the Defence and Security, Energy, Health and Consumer sectors. Our professional networks bridge artificial intelligence, automated creativity, electronics, energy, materials, nanotechnology and software. We invent and innovate in-house, foster high-potential technologies, and aggregate capabilities globally, to produce innovative, disruptive products that deliver more than the sum of their parts. By providing technical, executive, commercial and capital support, our Innovation-Exploitation Programme enhances value proposition and reduces risk exposure, while developing creativity, flexibility and robustness. Our goal is for our ‘wrap around’ idea to patent to product approach to become recognised globally as a catalyst for successful innovation. We are bridging the challenging gap between ‘thinking’ and ‘doing’.

Glaia is a company that specializes in developing nanotechnology-based solutions aimed at promoting sustainable agriculture. By focusing on enhancing food security and addressing climate change, Glaia's products improve the efficiency with which plants harvest light and optimize biomass production processes. This results in increased crop yields, enabling farmers to enhance agricultural productivity while reducing the strain on natural resources. Through its innovative approach, Glaia seeks to transform agricultural practices and support a more sustainable future.

Iceni Labs is an innovation commercialisation enterprise, with integrated research, development, test and manufacturing capability. Inter-disciplinary by nature, we combine commercial expertise with academic excellence, across the Defence and Security, Energy, Health and Consumer sectors. Our professional networks bridge artificial intelligence, automated creativity, electronics, energy, materials, nanotechnology and software. We invent and innovate in-house, foster high-potential technologies, and aggregate capabilities globally, to produce innovative, disruptive products that deliver more than the sum of their parts. By providing technical, executive, commercial and capital support, our Innovation-Exploitation Programme enhances value proposition and reduces risk exposure, while developing creativity, flexibility and robustness. Our goal is for our ‘wrap around’ idea to patent to product approach to become recognised globally as a catalyst for successful innovation. We are bridging the challenging gap between ‘thinking’ and ‘doing’.

Dyman Advanced Materials specializes in the development of a patented technology aimed at enhancing the manufacturing process of synthetic diamonds. This innovative approach seeks to improve the efficiency of the traditional high-pressure and high-temperature method used in diamond synthesis, resulting in reduced production costs. By providing a more economical production method, Dyman's technology serves both the industrial and gemstone market sectors, facilitating the broader availability of high-quality synthetic diamonds.

Anaphite Limited is a startup based in Bristol, United Kingdom, that specializes in the development of graphene-based nanomaterials. Founded in 2016, the company focuses on creating graphene-enhanced cathode materials designed for high-performance, cost-effective lithium-ion batteries. Anaphite's innovative approach incorporates graphene into composite materials through a scalable and economical process, resulting in advanced properties suitable for various applications, including energy storage, air purification, and thermal management. By making these nanomaterials readily accessible at a low cost, Anaphite aims to enable businesses to leverage their potential across multiple sectors.

Iceni Labs is an innovation commercialisation enterprise, with integrated research, development, test and manufacturing capability. Inter-disciplinary by nature, we combine commercial expertise with academic excellence, across the Defence and Security, Energy, Health and Consumer sectors. Our professional networks bridge artificial intelligence, automated creativity, electronics, energy, materials, nanotechnology and software. We invent and innovate in-house, foster high-potential technologies, and aggregate capabilities globally, to produce innovative, disruptive products that deliver more than the sum of their parts. By providing technical, executive, commercial and capital support, our Innovation-Exploitation Programme enhances value proposition and reduces risk exposure, while developing creativity, flexibility and robustness. Our goal is for our ‘wrap around’ idea to patent to product approach to become recognised globally as a catalyst for successful innovation. We are bridging the challenging gap between ‘thinking’ and ‘doing’.

Nanna Therapeutics Limited, established in 2012 and headquartered in Cambridge, UK, is a biotechnology company focused on developing drugs for age-related diseases such as mitochondrial, neurodegenerative, cardiovascular/metabolic, joint/tissue diseases, and cancer. As of April 2020, the company operates as a subsidiary of Astellas Pharma Europe Ltd. Nanna Therapeutics employs a unique approach by targeting fundamental cellular processes to create innovative treatments for these conditions, with a particular emphasis on mitochondria, the energy source in every cell. The company's proprietary drug discovery platform, TIME (Totally Integrated Medicines Engine), combines advanced technologies like microfluidics and artificial intelligence to accelerate drug development and disrupt traditional methods of creating new medicines.

Anaphite Limited is a startup based in Bristol, United Kingdom, that specializes in the development of graphene-based nanomaterials. Founded in 2016, the company focuses on creating graphene-enhanced cathode materials designed for high-performance, cost-effective lithium-ion batteries. Anaphite's innovative approach incorporates graphene into composite materials through a scalable and economical process, resulting in advanced properties suitable for various applications, including energy storage, air purification, and thermal management. By making these nanomaterials readily accessible at a low cost, Anaphite aims to enable businesses to leverage their potential across multiple sectors.

Beta Bugs is an insect genetics company specializing in the development and distribution of high-performance Black Soldier Fly breeds aimed at enhancing productivity in the insect protein sector. The company operates a breeding program called HiPer-Fly® and maintains a dedicated egg production site known as The Multiplier®, supplying its breeds to both UK and international markets. By focusing on biotechnology and breeding techniques, Beta Bugs aims to create a sustainable protein source that can effectively replace traditional feed ingredients such as fishmeal and soymeal in livestock, aquaculture, and pet feed. Headquartered at the Easter Bush Campus, a recognized center for animal genetics, Beta Bugs collaborates closely with the Roslin Institute, noted for its pioneering work in animal genetics.

Irresistible Materials Ltd is a materials technology company based in Swansea, United Kingdom, specializing in the development and commercialization of fullerene-based photoresist technology. Founded in 2010 as a spin-out from the University of Birmingham, the company collaborates with Nano-C Inc in the United States to create advanced materials for next-generation lithography applications. Irresistible Materials focuses on providing innovative solutions, including EUV resists, spin-on-carbon, and e-beam resists, aimed at meeting the demands of the semiconductor industry for increasingly smaller microchip feature sizes. The company has established a robust patent portfolio that encompasses various resist and hard-mask materials and maintains strong partnerships with the University of Birmingham and a network of global collaborators to further advance its materials offerings.

Xerion Healthcare Limited is a biotechnology company based in Thame, United Kingdom, specializing in the development and commercialization of nanoparticle treatments for cancer. Founded in 2015, the company focuses on enhancing the efficacy of conventional radiotherapy by utilizing nanoparticles made from titanium dioxide, a non-toxic semiconductor material. These nanoparticles are injected into tumors prior to standard radiotherapy, where they amplify the generation of free radicals produced by X-rays, thereby improving treatment outcomes. Xerion Healthcare is particularly concentrated on developing its innovative technology for head, neck, and pancreatic cancers, aiming to provide more effective therapies while minimizing side effects for patients.

LIFNano Therapeutics is a clinical-stage biotechnology company founded in 2013 as a spin-out from the University of Cambridge. The company specializes in the targeted delivery of Leukaemia Inhibitory Factor (LIF), utilizing advanced nanotechnology to develop therapeutics aimed at treating multiple sclerosis and other neurodegenerative diseases. By focusing on the precise delivery of biologics, LIFNano aims to repair damaged tissues, particularly neurons in the brain and spinal cord. This approach provides patients with a potential natural treatment option for multiple sclerosis and inflammatory diseases affecting the brain and immune system.

Tecrea Ltd is involved in basic research that results in transformative technologies for biomedicine. We focus on creative ways to use nanotechnology to improve cell delivery of reagents and drugs. We view cell delivery as a central problem in biological research and biomedicine, and improved delivery strategies can enable better application of many reagents and drugs. By improving delivery, Tecrea Ltd enables scientists to bring forward modern molecular medicines to the clinic.